Maravai LifeSciences Holdings Inc (MRVI)
7.70
+0.12
(+1.58%)
USD |
NASDAQ |
Apr 26, 16:00
7.70
0.00 (0.00%)
After-Hours: 20:00
Maravai LifeSciences Holdings Cash from Operations (Quarterly): 7.79M for Dec. 31, 2023
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 7.79M |
September 30, 2023 | 14.17M |
June 30, 2023 | 19.19M |
March 31, 2023 | 85.07M |
December 31, 2022 | 99.34M |
September 30, 2022 | 110.06M |
June 30, 2022 | 164.28M |
March 31, 2022 | 162.30M |
Date | Value |
---|---|
December 31, 2021 | 58.74M |
September 30, 2021 | 105.56M |
June 30, 2021 | 165.94M |
March 31, 2021 | 38.33M |
December 31, 2020 | 79.43M |
September 30, 2020 | 51.43M |
June 30, 2020 | 11.62M |
March 31, 2020 | 9.713M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
7.79M
Minimum
Dec 2023
165.94M
Maximum
Jun 2021
73.93M
Average
69.09M
Median
Cash from Operations (Quarterly) Benchmarks
ModivCare Inc | -25.64M |
Dyadic International Inc | -0.9234M |
Enveric Biosciences Inc | -1.751M |
Monopar Therapeutics Inc | -1.546M |
SeaStar Medical Holding Corp | -4.485M |
Cash from Operations (Quarterly) Related Metrics
Cash from Investing (Quarterly) | -12.90M |
Cash from Financing (Quarterly) | 0.47M |
Free Cash Flow | 60.67M |
Free Cash Flow Per Share (Quarterly) | -0.0682 |
Free Cash Flow to Equity (Quarterly) | -8.196M |
Free Cash Flow to Firm (Quarterly) | -10.34M |
Free Cash Flow Yield | 5.97% |